CS logo
small CS logo
Illinois eye and ear infirmary

Chicago, Illinois, United States
Eye care center in Chicago, Illinois
1855 W Taylor St, Chicago, IL 60612

About Illinois eye and ear infirmary


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
University of Illinois at Chicago
3
Genentech, Inc.
2
Sandeep Jain, MD
2
Joseph B. Ciolino, MD
1
Quark Pharmaceuticals
1
Total Rows: 5

Clinical Trials at Illinois eye and ear infirmary


During the past decade, Illinois eye and ear infirmary conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11110022221100110000001111000000Started TrialsCompleted Trails201620172018201920202021202220230123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients
2010-02-01
2013-04-01
Completed
48
Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit
2017-03-15
2021-08-31
Completed
69
Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)
2016-05-01
2017-04-13
Terminated
15
A Study Assessing the Safety, Tolerability, and Efficacy of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)
2019-06-03
2022-10-27
Terminated
360
IVIG-eye Drops Treatment for Dry Eye Disease
2019-05-01
2019-08-02
Completed
27
OSIG-eye Drops Treatment for Dry Eye Disease
2023-05-15
2024-01-20
Not yet recruiting
40
Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients
2020-11-01
2021-11-01
Recruiting
40
A Study Assessing the Long-Term Safety and Tolerability of Galegenimab (FHTR2163) in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2020-11-16
2022-11-14
Terminated
144

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Illinois eye and ear infirmary" #1 sponsor was "University of Illinois at Chicago" with 3 trials, followed by "Genentech, Inc." with 2 trials sponsored, "Sandeep Jain, MD" with 2 trials sponsored, "Joseph B. Ciolino, MD" with 1 trials sponsored and "Quark Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois eye and ear infirmary" #1 collaborator was "Illinois Society for the Prevention of Blindness" with 1 trials as a collaborator, "Ocugen" with 1 trials as a collaborator, "United States Department of Defense" with 1 trials as a collaborator and "VitreoRetinal Surgery Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversity of Illinois atChicago: 3University of Illinois atChicago: 3Genentech, Inc.: 2Genentech, Inc.: 2Sandeep Jain, MD: 2Sandeep Jain, MD: 2Joseph B. Ciolino, MD: 1Joseph B. Ciolino, MD: 1Quark Pharmaceuticals: 1Quark Pharmaceuticals: 1

Created with Highcharts 11.1.0Top CollaboratorsIllinois Society for thePrevention ofBlindness: 1Illinois Society for thePrevention ofBlindness: 1Ocugen: 1Ocugen: 1United StatesDepartment of Defense:1United StatesDepartment of Defense:1VitreoRetinal SurgeryFoundation: 1VitreoRetinal SurgeryFoundation: 1

Clinical Trials Conditions at Illinois eye and ear infirmary


According to Clinical.Site data, the most researched conditions in "Illinois eye and ear infirmary" are "Dry Eye" (3 trials), "Geographic Atrophy" (2 trials), "Macular Degeneration, Age-Related" (2 trials), "Age Related Macular Degeneration" (1 trials) and "Keratoconus" (1 trials). Many other conditions were trialed in "Illinois eye and ear infirmary" in a lesser frequency.

Clinical Trials Intervention Types at Illinois eye and ear infirmary


Most popular intervention types in "Illinois eye and ear infirmary" are "Drug" (8 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Galegenimab" (2 trials), "Brimonidine 0.075%" (1 trials), "Brimonidine 0.15%" (1 trials) and "Corneal gas permeable lens" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Illinois eye and ear infirmary


The vast majority of trials in "Illinois eye and ear infirmary" are 9 trials for "All" genders.

Clinical Trials Status at Illinois eye and ear infirmary


Currently, there are NaN active trials in "Illinois eye and ear infirmary". 1 are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Illinois eye and ear infirmary, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Illinois eye and ear infirmary, 4 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 6Phase 2: 6Phase 1: 4Phase 1: 4Early Phase 1: 1Early Phase 1: 1Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Terminated: 3Terminated: 3Recruiting: 2Recruiting: 2Not yet recruiting: 1Not yet recruiting: 1